MARSHALL WACE, LLP - FIVE PRIME THERAPEUTICS INC ownership

FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 151 filers reported holding FIVE PRIME THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.75 and the average weighting 0.3%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of FIVE PRIME THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$592,000
-46.8%
34,811
-87.9%
0.00%
-66.7%
Q3 2019$1,113,000
-46.8%
286,782
-17.4%
0.01%
-47.1%
Q2 2019$2,094,000
+711.6%
347,343
+2215.6%
0.02%
+54.5%
Q1 2018$258,000
-97.4%
15,000
-93.7%
0.01%
-88.0%
Q4 2015$9,841,000
+285.5%
237,141
+43.0%
0.09%
+196.8%
Q3 2015$2,553,000165,8790.03%
Other shareholders

There were no reported owners of FIVE PRIME THERAPEUTICS INC in Q1 2021.

NameSharesValueWeighting ↓
View complete list of FIVE PRIME THERAPEUTICS INC shareholders